Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70:145–64.

Article  PubMed  Google Scholar 

Kraus S, Arber N. Inflammation and colorectal cancer. Curr Opin Pharmacol. 2009;9:405–10.

Article  CAS  PubMed  Google Scholar 

Marzo VD, Bifulco M, Petrocellis LD. The endocannabinoid system and its therapeutic exploitation. Nat Rev Drug Discov. 2004;3:771–84.

Article  PubMed  Google Scholar 

Schwarz R, Ramer R, Hinz B. Targeting the endocannabinoid system as a potential anticancer approach. Drug Metab Rev. 2018;50:26–53.

Article  CAS  PubMed  Google Scholar 

Sarsembayeva A, Schicho R. Cannabinoids and the endocannabinoid system in immunotherapy: helpful or harmful?. Front Oncol. 2023;13:1296906.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guindon J, Hohmann A. Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain. Br J Pharmacol. 2008;153:319–34.

Article  CAS  PubMed  Google Scholar 

Lunn CA, Reich E-P, Bober L. Targeting the CB2 receptor for immune modulation. Expert Opin Ther Targets. 2006;10:653–63.

Article  CAS  PubMed  Google Scholar 

Iden JA, Raphael-Mizrahi B, Awida Z, Naim A, Zyc D, Liron T, et al. The anti-tumorigenic role of cannabinoid receptor 2 in colon cancer: a study in mice and humans. Int J Mol Sci. 2023;24:4060.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Iden JA, Raphael-Mizrahi B, Naim A, Kolomansky A, Liron T, Neumann D, et al. The anti-tumorigenic role of cannabinoid receptor 2 in non-melanoma skin cancer. Int J Mol Sci. 2023;24:7773.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Raphael-Mizrahi B, Attar-Namdar M, Chourasia M, Cascio MG, Shurki A, Tam J, et al. Osteogenic growth peptide is a potent anti-inflammatory and bone preserving hormone via cannabinoid receptor type 2. Elife. 2022;11:e65834.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pigossi SC, Medeiros MC, Saska S, Cirelli JA, Scarel-Caminaga RM. Role of osteogenic growth peptide (OGP) and OGP (10–14) in bone regeneration: a review. Int J Mol Sci. 2016;17:1885.

Article  PubMed  PubMed Central  Google Scholar 

Zhang T, Zhou M, Xiao D, Liu Z, Jiang Y, Feng M, et al. Myelosuppression alleviation and hematopoietic regeneration by tetrahedral-framework nucleic-acid nanostructures functionalized with osteogenic growth peptide. Adv Sci. 2022;9:2202058.

Article  CAS  Google Scholar 

Xu P, He H, Gu Y, Wang Y, Sun Z, Yang L, et al. Surgical trauma contributes to progression of colon cancer by downregulating CXCL4 and recruiting MDSCs. Exp Cell Res. 2018;370:692–8.

Article  CAS  PubMed  Google Scholar 

Jayakumar A, Bothwell AL. Stat6 promotes intestinal tumorigenesis in a mouse model of adenomatous polyposis by expansion of MDSCs and inhibition of cytotoxic CD8 response. Neoplasia. 2017;19:595–605.

Article  PubMed  PubMed Central  Google Scholar 

Millrud CR, Bergenfelz C, Leandersson K. On the origin of myeloid-derived suppressor cells. Oncotarget. 2017;8:3649.

Article  PubMed  Google Scholar 

Groth C, Hu X, Weber R, Fleming V, Altevogt P, Utikal J, et al. Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression. Br J Cancer. 2019;120:16–25.

Article  CAS  PubMed  Google Scholar 

Chen J, Ye Y, Liu P, Yu W, Wei F, Li H, et al. Suppression of T cells by myeloid-derived suppressor cells in cancer. Hum Immunol. 2017;78:113–9.

Article  CAS  PubMed  Google Scholar 

Mandruzzato S, Solito S, Falisi E, Francescato S, Chiarion-Sileni V, Mocellin S, et al. IL4Rα+ myeloid-derived suppressor cell expansion in cancer patients. J Immunol. 2009;182:6562–8.

Article  CAS  PubMed  Google Scholar 

Sinha P, Parker KH, Horn L, Ostrand-Rosenberg S. Tumor-induced myeloid-derived suppressor cell function is independent of IFN-γ and IL-4 R α. European J Immunol. 2012;42:2052–9.

Article  CAS  Google Scholar 

Weber R, Groth C, Lasser S, Arkhypov I, Petrova V, Altevogt P, et al. IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy. Cell Immunol. 2021;359:104254.

Article  CAS  PubMed  Google Scholar 

Turano M, Cammarota F, Duraturo F, Izzo P, De Rosa M. A potential role of IL-6/IL-6R in the development and management of colon cancer. Membranes. 2021;11:312.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng T, Hong X, Wang J, Pei T, Liang Y, Yin D, et al. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma. Hepatology. 2014;59:935–46.

Article  CAS  PubMed  Google Scholar 

Koller FL, Hwang DG, Dozier E, Fingleton B. Epithelial interleukin-4 receptor expression promotes colon tumor growth. Carcinogenesis. 2010;31:1010–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Becker W, Alrafas HR, Wilson K, Miranda K, Culpepper C, Chatzistamou I, et al. Activation of cannabinoid receptor 2 prevents colitis-associated colon cancer through myeloid cell de-activation upstream of IL-22 production. Iscience. 2020;23:101504.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ghonim MA, Ibba SV, Tarhuni AF, Errami Y, Luu HH, Dean MJ, et al. Targeting PARP-1 with metronomic therapy modulates MDSC suppressive function and enhances anti-PD-1 immunotherapy in colon cancer. J Immunother Cancer. 2021;9:e001643.

Article  PubMed  PubMed Central  Google Scholar 

Jala VR, Bodduluri SR, Ghosh S, Chheda Z, Singh R, Smith ME, et al. Absence of CCR2 reduces spontaneous intestinal tumorigenesis in the ApcMin/+ mouse model. Int J Cancer. 2021;148:2594–607.

Article  CAS  PubMed  Google Scholar 

Jou E, Rodriguez-Rodriguez N, Ferreira A-CF, Jolin HE, Clark PA, Sawmynaden K, et al. An innate IL-25–ILC2–MDSC axis creates a cancer-permissive microenvironment for Apc mutation-driven intestinal tumorigenesis. Sci Immunol. 2022;7:eabn0175.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moser A, Luongo C, Gould KA, McNeley M, Shoemaker A, Dove W. ApcMin: a mouse model for intestinal and mammary tumorigenesis. Eur J Cancer. 1995;31:1061–4.

Article  Google Scholar 

Ren J, Sui H, Fang F, Li Q, Li B. The application of Apc Min/+ mouse model in colorectal tumor researches. J Cancer Res Clin Oncol. 2019;145:1111–22.

Article  CAS  PubMed  Google Scholar 

Wang J, Fernald AA, Anastasi J, Le Beau MM, Qian Z. Haploinsufficiency of Apc leads to ineffective hematopoiesis. Blood, J Am Soc Hematol. 2010;115:3481–8.

CAS  Google Scholar 

Yamada Y, Mori H. Multistep carcinogenesis of the colon in ApcMin/+ mouse. Cancer Sci. 2007;98:6–10.

Article  CAS  PubMed  Google Scholar 

Kettunen HL, Kettunen AS, Rautonen NE. Intestinal immune responses in wild-type and Apc min/+ mouse, a model for colon cancer. Cancer Res. 2003;63:5136–42.